C. David Adair

Chairman, Chief Scientific Officer & Founder at Glenveigh Medical LLC

C. David Adair

C. David Adair

Chairman, Chief Scientific Officer & Founder at Glenveigh Medical LLC

Overview
Career Highlights

Glenveigh Medical LLC

RelSci Relationships

80

Number of Boards

8

Relationships
RelSci Relationships are individuals C. David Adair likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Katan Associates International

Relationship likelihood: Strong

President & Chief Executive Officer at Veran Medical Technologies, Inc.

Relationship likelihood: Strong

Co-Founder & Managing Director at Solas Bioventures (mayfield) LLC

Relationship likelihood: Strong

Chief Executive Officer at Advanced Catheter Therapies, Inc.

Relationship likelihood: Strong

Vice Chairman at Veran Medical Technologies, Inc.

Relationship likelihood: Strong

Co-Founder at Aerial BioPharma LLC

Relationship likelihood: Strong

Partner at XMi High Growth Development LLC

Relationship likelihood: Strong

Co-Founder at Aerial BioPharma LLC

Relationship likelihood: Strong

Co-Founder at Advanced Catheter Therapies, Inc.

Relationship likelihood: Strong

Former Physician at Greater Cincinnati OB/GYN, Inc.

Relationship likelihood: Strong

Paths to C. David Adair
Potential Connections via
Relationship Science
You
C. David Adair
Chairman, Chief Scientific Officer & Founder at Glenveigh Medical LLC
Career History
Chairman, Chief Scientific Officer & Founder
2004 - Current

Glenveigh Medical LLC develops drugs and devices to prevent the causes of premature births. Its products include Ebb, a tamponade solution for postpartum hemorrhage; Jetty, a solution for episiotomy and vaginal laceration repair; and Beacon, a fetal monitor. The company was founded by C. David Adair in 2004 and is headquartered in Chattanooga, TN.

Managing Director
Current

Solas Bioventures invests in life sciences companies located in the US. The firm targets the companies operating in the fields of biopharmaceuticals, medical devices, diagnostics, digital health technologies. It provides financing for early and development stage capital requirements.

Boards & Committees
Member, Board of Directors
2021 - Current

Intershunt Technologies, Inc. is a company headquartered in Saint Louis, MO, that designs and develops catheter based minimally-invasive procedure to provide relief for millions suffering from heart failure. The firm was founded by Gil Vardi. Harlee L. Sorkin is the current CEO of the company.

Director
2020 - Current

BioStable Science & Engineering, Inc. engagses in the develop of products for the treatment of cardiovascular disease. It covers areas of product development including quality systems, design, engineering, prototyping and pilot production, in-vitro and in-vivo testing, manufacturing, global regulatory relationships, clinical product validation, market launch, and distribution. The firm provides a competitive edge by minimizing time to market for cost effective medical devices that deliver improved clinical outcomes. The company was founded by Al Alan Beavan, Charles D. Griffin, Douglas Charles Frank, Don James, J. Scott Rankin and Rusty Phillips in 2008 and is headquartered in Austin, TX.

Member, Board of Directors
Current

AEGEA Medical, Inc. develops technology that utilizes convective water vapor to treat menorrhagia. The firm focuses on the development of its proprietary and innovative water vapor treatment for abnormal uterine bleeding. It has vapor system delivers controlled, low-pressure natural water vapor to the uterine cavity to efficiently ablate the inner lining of the uterus. The company was founded by Paul M. Goeld in 2008 and is headquartered in Redwood City, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by C. David Adair. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of C. David Adair's profile does not indicate a business or promotional relationship of any kind between RelSci and C. David Adair.